Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry.

Asta Theodorsdottir,Birgit Debrabant,Melinda Magyari,Matthias Kant,Peter Rasmussen,Carl-Fredrik Malmberg,Iver A Norberg,Victoria Hansen,Danny Bech,Mathias F Schmidt,Karen Schreiber,Jette L. Frederiksen,Finn Sellebjerg,Zsolt Illes

Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry.

2021

Asta Theodorsdottir
Birgit Debrabant
Melinda Magyari
Matthias Kant
Peter Rasmussen
Carl-Fredrik Malmberg
Iver A Norberg
Victoria Hansen
Danny Bech
Mathias F Schmidt
Karen Schreiber
Jette L. Frederiksen
Finn Sellebjerg
Zsolt Illes

Objective:To investigate clinical outcomes in a real-world setting in the complete population-based cohort of alemtuzumab-treated MS patients in Denmark.Methods:Data were retrieved from The Danish ...

Keywords:

Danish
Alemtuzumab
Cohort
Multiple sclerosis
Medicine
Observational study
Population
Adverse effect
Pediatrics
national study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations